KNSA
Kiniksa Pharmaceuticals InternaWhen KNSA passed all Ten ChecksKiniksa Pharmaceuticals Interna
history · not a forecastOver the past 10 years, KNSA has passed all Ten Checks on 9 separate days. Here is how it moved over the 20 trading sessions that followed — how far it rose, and how far it fell.
The strongest of them rose +18.2% in Nov 2018, still rising at session 20.
- Feb 2026+7.7% -3.6%
- Nov 2025+8.1% +1.4%
- Sep 2025+6.9% +1.5%
Peak and dip mark the highest and lowest closing prices over those 20 sessions; the intraday swings ran wider still, and neither figure is a return you could have captured by buying and selling at the perfect moment. These are historical readings from the past 10 years, drawn only from the US-listed stocks the site covers today — a record of what happened, not a prediction of what will, and not investment advice.
6-month history — checks vs. price
Price on the left axis; checks passing (0–10) on the right.
Common questions about KNSA’s checks
How many technical checks does KNSA pass right now?
As of the Aug 13, 2026 close, KNSA passes 7 of 10 fixed technical checks — the checks not passing: pulled back to support, not overextended, adequate stop room.
Why does KNSA fail the "adequate stop room" check?
The stop sits only 0.7× the average daily range (ATR) from price — inside the 1-ATR minimum, so this check fails (normal noise could hit it). It passes once there's at least 1× ATR of room.
What price would change KNSA's check count?
The nearest flip level is "stop distance within range" fails on a close outside $76.52 – $81.51. Each price-anchored check has an exact next-close level, shown in the Flip levels panel above.
Factual measurements from the latest scan — not investment advice.